Status:
COMPLETED
Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer
Lead Sponsor:
NSABP Foundation Inc
Collaborating Sponsors:
National Cancer Institute (NCI)
Northern California Cancer Center
Conditions:
Colorectal Cancer
Eligibility:
All Genders
Up to 70 years
Phase:
PHASE3
Brief Summary
RATIONALE: Drugs used in chemotherapy, such as fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Leucovorin may hel...
Detailed Description
OBJECTIVES: I. Compare, in a Phase III setting, disease-free survival and overall survival of patients who have undergone potentially curative resection of Dukes' B or C carcinoma of the colon randoml...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS: See General Eligibility Criteria
- PATIENT CHARACTERISTICS: See General Eligibility Criteria
Exclusion
Key Trial Info
Start Date :
July 1 1989
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2004
Estimated Enrollment :
2151 Patients enrolled
Trial Details
Trial ID
NCT00425152
Start Date
July 1 1989
End Date
April 1 2004
Last Update
February 8 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.